Lex: FT's flagship investment column
Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
，这一点在WPS下载最新地址中也有详细论述
Dorsey also said the company’s customer base is expanding and profitability is improving, which he attributed to AI implementation.
function mockToString(target, name) {